Celebrity-Backed Cannabis Beverage Brand 'Cann' Acquires CBD Drink Maker Sweet Reason

California-based cannabis-infused beverage company Cann announced Tuesday it has acquired CBD drink maker Sweet Reason. Terms of the deal were not disclosed.

With this purchase, Cann is aiming to establish a non-CBD format of Sweet Reason to avoid regulatory challenges. Additionally, Sweet Reason’s founder and CEO joins Cann as SVP of Emerging Products in order to drive sales and distribution, innovation and product development for all portfolio brands.

While Cann is microdosed with 2mg of THC and 4mg of CBD, the brand is considering an ever further microdosed THC-infused drink under the Sweet Reason brand for anyone who finds Cann’s buzz overwhelming. Cann sees the “micro-microdose” as a huge untapped market within the cannabis space, and plans to build it out through this acquisition.

Cann's is also famous for its growing list of celebrity investors, including Adam Devine, Gwyneth Paltrow, Rebel Wilson, Ruby Rose, Darren Criss, Baron Davis, Tove Lo, Casey Neistat and Bre-Z, who recognize the power of a better-for-you, alcohol alternative that still delivers a social buzz.

Related News:

'Workaholics' Actor Adam Devine Talks Cannabis: 'I'm Basically A 50's Dad, But Instead Of Whisky I Do Weed

Photo: Courtesy of geralt, lindsayfox by Pixabay

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisM&ANewsMarketsBaron DavisBre-ZCannCannabis Drink CannCasey Neistatdam DevineDarren CrissGwyneth PaltrowRebel WilsonRuby RoseSweet ReasonTove Lo
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.